Works matching IS 0008543X AND DT 2005 AND VI 104 AND IP 7

Results: 33
    1

    Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence.

    Published in:
    2005
    By:
    • Larson, Richard A;
    • Sievers, Eric L;
    • Stadtmauer, Edward A;
    • Löwenberg, Bob;
    • Estey, Elihu H;
    • Dombret, Hervé;
    • Theobald, Matthias;
    • Voliotis, Dimitris;
    • Bennett, John M;
    • Richie, Maria;
    • Leopold, Lance H;
    • Berger, Mark S;
    • Sherman, Matthew L;
    • Loken, Michael R;
    • van Dongen, Jacques J M;
    • Bernstein, Irwin D;
    • Appelbaum, Frederick R
    Publication type:
    journal article
    2
    3
    4
    5
    6
    7

    Author reply.

    Published in:
    Cancer (0008543X), 2005, v. 104, n. 7, p. 1557, doi. 10.1002/cncr.21345
    By:
    • Joseph M. Unger;
    • Michael LeBlanc;
    • Ian M. Thompson;
    • Charles A. Coltman
    Publication type:
    Article
    8
    9
    10
    11
    12
    13

    Incidence and risk factors for the occurrence of non‐AIDS‐defining cancers among human immunodeficiency virus‐infected individualsThis is a U.S. government work and, as such, is in the public domain in the United States of America.Presented in condensed form as abstract 886 at the 42nd Annual Meeting of the Infectious Diseases Society of America, Boston, Massachusetts, September 30–October 3, 2004.

    Published in:
    Cancer (0008543X), 2005, v. 104, n. 7, p. 1505, doi. 10.1002/cncr.21334
    By:
    • Alina Burgi;
    • Stephanie Brodine;
    • Scott Wegner;
    • Mark Milazzo;
    • Mark R. Wallace;
    • Katherine Spooner;
    • David L. Blazes;
    • Brian K. Agan;
    • Adam Armstrong;
    • Susan Fraser;
    • Nancy F. Crum
    Publication type:
    Article
    14
    15
    16

    Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: A Multicenter European Study.

    Published in:
    Cancer (0008543X), 2005, v. 104, n. 7, p. 1362, doi. 10.1002/cncr.21331
    By:
    • Luca Cindolo;
    • Jean‐Jacques Patard;
    • Paolo Chiodini;
    • Luigi Schips;
    • Vincenzo Ficarra;
    • Jacques Tostain;
    • Alexandre de La Taille;
    • Vincenzo Altieri;
    • Bernard Lobel;
    • Richard E. Zigeuner;
    • Walter Artibani;
    • François Guillé;
    • Claude C. Abbou;
    • Luigi Salzano;
    • Ciro Gallo
    Publication type:
    Article
    17

    New aromatase inhibitors as second‐line endocrine therapy in postmenopausal patients with metastatic breast carcinomaPresented at the 40th Annual Meeting of the American Society of Clinical Oncology, New Orleans, Louisiana, June 5–8, 2004.: A pooled analysis of the randomized trials

    Published in:
    Cancer (0008543X), 2005, v. 104, n. 7, p. 1335, doi. 10.1002/cncr.21339
    By:
    • Paolo Carlini;
    • Emilio Bria;
    • Diana Giannarelli;
    • Gianluigi Ferretti;
    • Alessandra Felici;
    • Paola Papaldo;
    • Alessandra Fabi;
    • Cecilia Nisticò;
    • Serena Di Cosimo;
    • Enzo Maria Ruggeri;
    • Michele Milella;
    • Marcella Mottolese;
    • Edmondo Terzoli;
    • Francesco Cognetti
    Publication type:
    Article
    18
    19

    The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumors.

    Published in:
    Cancer (0008543X), 2005, v. 104, n. 7, p. 1468, doi. 10.1002/cncr.21338
    By:
    • J. Matthew McDonald;
    • Siew Ju See;
    • Ivo W. Tremont;
    • Howard Colman;
    • Mark R. Gilbert;
    • Morris Groves;
    • Peter C. Burger;
    • David N. Louis;
    • Caterina Giannini;
    • Gregory Fuller;
    • Sandra Passe;
    • Hilary Blair;
    • Robert B. Jenkins;
    • Helen Yang;
    • Alicia Ledoux;
    • Joann Aaron;
    • Ulka Tipnis;
    • Wei Zhang;
    • Kenneth Hess;
    • Ken Aldape
    Publication type:
    Article
    20
    21
    22

    Osteoporosis and rate of bone loss among postmenopausal survivors of breast cancerShort list of Women's Health Initiative investigators:Program Office (National Heart, Lung, and Blood Institute, Bethesda, Maryland): Barbara Alving, Jacques Rossouw, Linda Pottern.Clinical Coordinating Center (Fred Hutchinson Cancer Research Center, Seattle, WA) Ross Prentice, Garnet Anderson, Andrea LaCroix, Ruth E. Patterson, Anne McTiernan; (Wake Forest University School of Medicine, Winston‐Salem, NC) Sally Shumaker, Pentti Rautaharju; (Medical Research Labs, Highland Heights, KY) Evan Stein; (University of California at San Francisco, San Francisco, CA) Steven Cummings; (University of Minnesota, Minneapolis, MN) John Himes; (University of Washington, Seattle, WA) Bruce Psaty.Clinical Centers: (Albert Einstein College of Medicine, Bronx, NY) Sylvia Wassertheil‐Smoller; (Baylor College of Medicine, Houston, TX) Jennifer Hays; (Brigham and Women's Hospital, Harvard Medical School, Boston, MA) JoAnn M

    Published in:
    Cancer (0008543X), 2005, v. 104, n. 7, p. 1520, doi. 10.1002/cncr.21335
    By:
    • Zhao Chen;
    • Michael Maricic;
    • Mary Pettinger;
    • Cheryl Ritenbaugh;
    • Ana Maria Lopez;
    • David H. Barad;
    • Margery Gass;
    • Meryl S. LeBoff;
    • Tamsen L. Bassford
    Publication type:
    Article
    23
    24
    25

    Caspase 8 is absent or low in many ex vivo gliomas.

    Published in:
    Cancer (0008543X), 2005, v. 104, n. 7, p. 1487, doi. 10.1002/cncr.21323
    By:
    • David M. Ashley;
    • Christopher D. Riffkin;
    • Andrea M. Muscat;
    • Melissa J. Knight;
    • Andrew H. Kaye;
    • Ulrike Novak;
    • Christine J. Hawkins
    Publication type:
    Article
    26

    Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma.

    Published in:
    Cancer (0008543X), 2005, v. 104, n. 7, p. 1478, doi. 10.1002/cncr.21316
    By:
    • David A. Reardon;
    • Jennifer A. Quinn;
    • Jeremy N. Rich;
    • Annick Desjardins;
    • James Vredenburgh;
    • Sridharan Gururangan;
    • Sith Sathornsumetee;
    • Michael Badruddoja;
    • Roger McLendon;
    • James Provenzale;
    • James E. Herndon;
    • Jeannette M. Dowell;
    • Jill L. Burkart;
    • Herbert B. Newton;
    • Allan H. Friedman;
    • Henry S. Friedman
    Publication type:
    Article
    27
    28

    Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33‐positive acute myeloid leukemia in first recurrence.

    Published in:
    Cancer (0008543X), 2005, v. 104, n. 7, p. 1442, doi. 10.1002/cncr.21326
    By:
    • Richard A. Larson;
    • Eric L. Sievers;
    • Edward A. Stadtmauer;
    • Bob Löwenberg;
    • Elihu H. Estey;
    • Hervé Dombret;
    • Matthias Theobald;
    • Dimitris Voliotis;
    • John M. Bennett;
    • Maria Richie;
    • Lance H. Leopold;
    • Mark S. Berger;
    • Matthew L. Sherman;
    • Michael R. Loken;
    • Jacques J. M. van Dongen;
    • Irwin D. Bernstein;
    • Frederick R. Appelbaum
    Publication type:
    Article
    29

    Phase I trial and pharmacokinetics of escalating doses of paclitaxel and concurrent hyperfractionated radiotherapy with or without amifostine in patients with advanced head and neck carcinomaPreliminary results were presented at the Thirty‐Seventh Annual Meeting of the American Society of Clinical Oncology, San Francisco, California, May 12–15, 2001.

    Published in:
    Cancer (0008543X), 2005, v. 104, n. 7, p. 1418, doi. 10.1002/cncr.21312
    By:
    • Philip C. Amrein;
    • John R. Clark;
    • Jeffrey G. Supko;
    • Richard L. Fabian;
    • Chiu C. Wang;
    • A. Dimitrios Colevas;
    • Marshall R. Posner;
    • Daniel G. Deschler;
    • James W. Rocco;
    • Dianne M. Finkelstein;
    • James F. McIntyre
    Publication type:
    Article
    30

    Wide excision without radiation for desmoplastic melanoma.

    Published in:
    Cancer (0008543X), 2005, v. 104, n. 7, p. 1462, doi. 10.1002/cncr.21311
    By:
    • Alisha Arora;
    • Lori Lowe;
    • Lyndon Su;
    • Riley Rees;
    • Carol Bradford;
    • Vincent C. Cimmino;
    • Alfred E. Chang;
    • Timothy M. Johnson;
    • Michael S. Sabel
    Publication type:
    Article
    31
    32
    33